The Benefit of Add On DLBS1033 for Ischemic Stroke Patient

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

Also called NCT04425590

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose supportive care
Phase
Phase 2/3
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
Duta Wacana Christian University (from the registry)
Registry
  • NCT NCT04425590
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Indonesia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04425590. Randomized; no masking; primary purpose supportive care. Start 2020-04-01 (actual); primary completion 2020-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Benefit of Add On DLBS1033 for Ischemic Stroke Patient
Intervention (Drug)
DLBS1033
Intervention (Drug)
Aspirin
Intervention (Drug)
Statin
Intervention (Drug)
Vit B12
Lead sponsor
Duta Wacana Christian University (class: other)
Collaborator
Dexa Laboratories Of Biomolecular Science (class: not stated)

Record details

Record id
cardio:ct-nct04425590
Content hash
e4364ac89633b3399b0d4ce6770bca2d4edbd894ac5e9b9b1508754833381317